The results of percutaneous mitral commissurotomy were assessed in patients with restenosis after surgical commissurotomy.
Mitral restenosis after surgical commissurotomy is a topic of potential interest for percutaneous mitral commissurotomy (PMC) because in western countries, the proportion of recurrent mitral stenosis is increasing due to the decrease of new cases of rheumatic valve disease. Moreover, in the case of mitral restenosis, reoperation often consists of valve replacement with its inherent morbidity and mortality. Since the first report of PMC (1), its safety, immediate and midterm efficacy have been widely demonstrated (2) (3) (4) (5) . The feasibility of PMC has been documented in patients who had previously undergone surgical commissurotomy, with generally good immediate results (6 -13) . However, only one series reported midterm results and showed a more rapid deterioration at four years than in patients without prior commissurotomy (11) .
The aim of the present study is to analyze immediate and late results of PMC for restenosis in a large single-center series reporting a long follow-up, of up to eight years. This enables the prediction of immediate and late results to be analyzed, in order to improve patient selection.
METHODS
Study population. From March 1986 to June 1996, 232 patients underwent PMC for mitral restenosis after a previous surgical commissurotomy. They had undergone a total of 240 surgical commissurotomies: 184 patients had had one closed-heart commissurotomy (CHC), 40 had had one open-heart commissurotomy (OHC), and 8 had had repeat commissurotomies (repeat CHC in 1 patient, CHC then OHC in 7). Seven patients also had prior aortic valve replacement. All patients had experienced functional improvement following surgical commissurotomy. PMC was performed a mean of 16 Ϯ 8 years (range, 3 to 38 years) after surgical commissurotomy: 17 Ϯ 8 years after CHC and 11 Ϯ 5 years after OHC.
Procedure. The antegrade transvenous approach was used in all cases. There was a failure to perform an effective balloon dilation of the mitral valve in nine cases. Between 1986 and 1990, dilatation was performed using a singleballoon procedure in 7 patients (Trefoil 3 ϫ 12 mm), and then a double-balloon procedure in 95 cases (Trefoil 3 ϫ 10 mm or 3 ϫ 12 mm ϩ 15 or 19 mm balloon) (14) . The last 121 patients underwent PMC with the Inoue balloon, which has been systematically used since 1990, following the stepwise technique under echo guidance (15) .
Measurements.
Following echocardiography and fluoroscopy, mitral valve anatomy was classified in three anatomic groups as previously described (3, 14, 16) : flexible valves and mild subvalvular disease (length of chordae Ն10 mm) (group 1); flexible valves and extensive subvalvular disease (length of chordae Ͻ10 mm) (group 2); and calcified valves as confirmed by fluoroscopy (group 3). In 40 patients of our global series, the mean (Ϯ SD) Wilkins' score was 8.0 Ϯ 0.8 (range, 7 to 9) for anatomic group 1, 9.9 Ϯ 1.3 (range, 8 to 12) for group 2 and 12.5 Ϯ 1.3 (range, 10 to 15) for group 3 (3).
When present, valve calcification was graded from 1 to 4 according to its extent on fluoroscopic examination: 45 patients were graded 1; 25 were graded 2; 9 were graded 3; and 2 were graded 4.
Echocardiographic examination was performed on the day preceding PMC and 24 to 48 h after the procedure to evaluate valve area by planimetry and Doppler pressure half-time, mean Doppler gradient and regurgitation by color Doppler. The reference measurement for valve area was planimetry by two-dimensional echocardiography. In cases of missing data, Doppler was used as substitution measurement (3) . Beginning in 1988, transesophageal echocardiography was performed systematically before the procedure to eliminate left atrial thrombosis.
Before and immediately after the procedure, the degree of mitral regurgitation was assessed according to Sellers' classification on left ventriculography in a 30°right anterior oblique view.
The effective balloon dilating area (EBDA) designs the area encompassed by the circumference of the outer halves of the two fully inflated balloons and the trapezoidal or square area connecting their two diameters for the doubleballoon technique and the area at the last inflation for the Inoue balloon (17) .
Exclusion criteria for PMC were bicommissural or massive calcification, mitral regurgitation Ͼ grade 2, left atrial thrombus and significant aortic valve or coronary artery disease.
In addition, patients were selected according to the status of the commissures as assessed by echocardiography on the parasternal short-axis view. Patients were considered for PMC only in the case of bilateral commissural fusion. When one or both commissures remained opened, restenosis was presumed to be mainly the consequence of a valvular and/or subvalvular rigidity and PMC was not attempted.
End point of good immediate results. Good immediate results of PMC were defined by a composite end point that associates a mitral valve area Ն1.5 cm 2 with no regurgitation Ͼ2/4 (3, 14) .
Follow-up. Follow-up was performed prospectively at oneyear intervals in patients who were residing in France at the time of their PMC and was assessed by patients' visits to the department or by a standardized questionnaire sent to the patient's cardiologist.
It was concluded in June 1997; patients were considered unavailable for follow-up if their last follow-up examination was before June 1996. Follow-up concerned 175 patients and its mean duration was 46 months (range, 1 to 122); 6 patients (3%) were unavailable for follow-up.
Clinical events were combined in the following end points: 
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CHC ϭ closed-heart commissurotomy EBDA ϭ effective balloon dilating area NYHA ϭ New York Heart Association OHC ϭ open-heart commissurotomy PMC ϭ percutaneous mitral commissurotomy probability of good immediate results for any given patient, according to his or her characteristics and procedure-related variables.
Cumulative survival curves were determined according to the Kaplan-Meier method. Univariate analysis of the predictive factors of late results was performed using a log-rank test. The dependent variable was the previously described composite end point "good functional results." Independent variables with p Ͻ 0.25 were entered in a multivariate Cox proportional hazards model and were selected by a backward procedure with a threshold of p ϭ 0.05. A predictive model of continuing good functional results at five years was then established using the Cox model, in which the baseline survival function So(t) was estimated from the study population.
All analyses was performed with statistical software (SAS Institute Inc., release 6.11).
RESULTS
Study population. The characteristics of the 232 patients are detailed in Table 1 . These patients represent 13% of the 1,741 procedures of PMC that were performed in our department during the same period.
Complications. The nine cases of failed procedures (4%) were related to tamponade in one case, inability to perform transseptal catheterization in two and to stabilize the balloon across the mitral orifice in six.
There was one in-hospital death (0.4%) in a 69-year-old woman who had previously undergone a transatrial CHC 21 years before and who had a massive tamponade immediately after the second balloon inflation using a double-balloon technique, suggesting a ventricular perforation. The other severe adverse events were severe mitral regurgitation Ն Sellers' grade 3 in 10 cases (4%). Six patients experienced transient ST-segment elevation after balloon inflation, suggesting gas embolism. There was no other embolic event, in particular no transient ischemic attack, and therefore no embolism leaving sequelae. No patient required surgery within the first 24 h following PMC.
Immediate results. Good immediate results as defined by the composite end point were obtained in 191 patients (82%). Poor immediate results were related to insufficient valve opening (valve area Ͻ1.5 cm 2 ) in 22 cases (10%) and to mitral regurgitation Ն Sellers' grade 3 in 10 (4%). The improvement of valvular function is shown in Table 2 .
The predictors of the immediate results in univariate analysis are shown in Table 3 .
The results of multivariate analysis are detailed in Table  4 : the significant predictors of poor immediate results were an older age (p Ͻ 0.0001), a lower valve area (p ϭ 0.01) and the use of the single-or double-balloon procedure as compared with the Inoue balloon (p ϭ 0.015). The good fit of the multivariate model to the observed data was demonstrated by the nonsignificant results of the Hosmer and Lemeshow goodness-of-fit test (chi-square ϭ 6.81, df ϭ 9, p ϭ 0.66). The prediction of immediate results according to the value of the three predictors for any given patient is shown on Table 5 .
Late results. In the 175 patients who underwent followup, the eight-year actuarial rates of global survival, survival considering only cardiovascular deaths, survival with no need for intervention and the composite end point of good functional results were, respectively, 78 Ϯ 4%, 90 Ϯ 3%, 55 Ϯ 6%, and 48 Ϯ 5% (Fig. 1) .
In the 148 patients who had had good immediate results of PMC, the 8-year rates of global survival, survival considering only cardiovascular deaths, survival with no need for intervention, and the composite end point of good functional results were, respectively, 86 Ϯ 4%, 97 Ϯ 2%, 
PMC for Restenosis After Surgical Commissurotomy died during follow-up. Three deaths were of cardiovascular origin, related to congestive heart failure, while the other 10 were noncardiac: respiratory insufficiency in 4, neoplasia in 3, cirrhosis in 1, AIDS in 1 and suicide in 1. In 24 patients, a subsequent intervention was required on the mitral valve. The type of intervention was an isolated mitral valve replacement in 13 cases, a mitral and aortic valve replacement in 3, an OHC in 3 and a repeat PMC in 5. The mean duration between PMC and the intervention was 46 months (range, 3 to 95). All the patients who underwent a new procedure on the mitral valve had mitral restenosis with a mean valve area of 1.1 Ϯ 0.2 cm 2 (range, 0.8 to 1.5); two patients also had moderate mitral regurgitation and three showed progression of an aortic valve disease. Finally, 11 patients were in NYHA class III or IV; they were waiting for an intervention or had contraindications to surgery.
The univariate analysis of the predictors of late functional results in the 148 patients who had had good immediate results of PMC is shown in Table 6 . The multivariate Cox analysis identified three predictors of poor late functional results after good immediate results of PMC (Table 7) . Two predictors were preprocedure variables, that is, a high cardiothoracic index (p Ͻ 0.0001) and a previous OHC (p ϭ 0.05). The third predictor was a lower valve area after PMC (p Ͻ 0.0001). The prediction of good functional results 5 years after good immediate results of PMC is shown on Table 8 .
Among the 27 patients who had had poor immediate results of PMC, there were 8 deaths, 7 from cardiovascular causes and 1 from extracardiac (neoplasia) causes. All the other 19 patients underwent surgery because of insufficient valve opening in 10 cases and mitral regurgitation Ն Sellers' grade 3 in 9. Surgery consisted of mitral valve replacement in 18 patients and OHC in 1 patient who had poor results from this surgery. The mean duration between PMC and the intervention was five months (range, 1 to 26), with 13 of 
DISCUSSION
This series further confirms the safety and immediate efficacy of PMC for restenosis after surgical commissurotomy, with 82% showing good immediate results. As concerns the late results, 48% of all patients were alive with no new intervention on the mitral valve, and with few or no symptoms at 8 years, with the corresponding figure being 58% after good immediate results. The prediction of the results is multifactorial: it depends on the patient characteristics, the technique used and the quality of the immediate results.
Restenosis after surgical commissurotomy. Progressive clinical deterioration has been shown to occur with a linear trend in different series reporting long-term follow-up after surgical commissurotomy (18 -20) . Mitral restenosis is one of the mechanisms of deterioration after surgical commissurotomy, the other causes being the consequence of unsatisfactory results of commissurotomy, with a residual stenosis or a severe mitral regurgitation (18, 19) . The incidence of restenosis can be estimated accurately only in studies comprising serial assessments of mitral valve area, both early after the procedure and during follow-up. The few studies available reported restenosis rates of 11% for a mean Figure 1 . Cumulated rates of late events after PMC for restenosis in the whole population who had undergone follow-up. 
follow-up of 6.5 years (21) and 28% for a mean follow-up of 11 years (22) . In the present study as in the literature, the sustained functional improvement following surgical commissurotomy and the duration between surgical commissurotomy and PMC (mean of 11 to 17 years) suggested restenosis after an initially successful procedure, rather than a residual stenosis after surgery (6, 7, 10, 12) .
Safety of PMC.
The low mortality of 0.4% in our series compares favorably with surgery. However, it should be stressed that the only death in our series was a tamponade, which can occur in patients who have undergone a previous surgical procedure despite frequent pericardial adherence (11) . Particular attention must be given to patients who have undergone transventricular CHC, because of the possibility of a residual apical aneurysm (10) . There was no embolism leaving sequelae; this can be related to the systematic use of transesophageal echocardiography since 1988. Despite the frequent exclusion of left atrial appendage after CHC, embolic risk is still present in these patients (23) . The frequency of severe traumatic mitral regurgitation was 4% in the present series, which is close to the 3.4% observed in our global experience of PMC (3). Series of PMC generally do not report higher rates of severe mitral regurgitation in patients with prior commissurotomy as compared with first procedure (7-13).
Immediate results of PMC. The composite end point of good immediate results used in this study associates a mitral valve area Ն1.5 cm 2 and no regurgitation Ͼ2/4, such conditions generally providing normal hemodynamics (3, 14, 24) .
The immediate results observed in our series were good, with 82% of patients having a valve area Ն1.5 cm 2 and no mitral regurgitation greater than Sellers' grade 2. Series of PMC for restenosis reported excellent immediate results in young populations, with no difference when compared with patients who did not have prior surgical intervention (7, 10, 12, 13) . Age is a predictor of immediate results in large series of PMC (2,3), but its predictive value is even more marked in patients with a history of commissurotomy, as illustrated by the value of odds-ratio in this study. This is in accordance with our global series of PMC, in which we found an interaction between age and previous commissurotomy, that is, an increase in the risk of poor immediate results in the case of prior commissurotomy only in patients aged Ͼ50 years (3). This explains that results were less satisfying in series including patients with a mean age Ͼ50 years (11) . As in other series of PMC, we found that valve area before PMC was a predictor of immediate results.
The last predictor of immediate results in our series was the technique used, with the Inoue balloon coming out better than the double-balloon technique. The published series of PMC for restenosis included only a few cases performed with the Inoue balloon (10, 12, 13) . Patients who have a history of prior commissurotomy have more severe impairment of valve anatomy. Our findings are consistent with the work of Feldman et al. (25) who showed that the impairment of valve anatomy was not a predictor of poor results of PMC when the Inoue balloon was used. The possibility of controlling valve opening by stepwise inflation under echo guidance might be an explanation for the apparent benefit of the Inoue balloon in case of impaired valve anatomy.
Valve calcification and the duration between surgery and PMC have been identified as predictors in other series (7-9), but not in ours. It should be noted that valve calcification, when present, was generally mild or moderate in the patients of our series.
Late results of PMC. In the present series, half of the patients who had undergone PMC for restenosis remained alive, with no intervention on the mitral valve, and in NYHA class I or II, 8 years after the procedure. To our knowledge, only the article of Jang et al. (11) has so far reported midterm results of PMC in 68 patients who had recurrent mitral stenosis after a previous commissurotomy. They reported a rate of survival without intervention and in NYHA class I or II of 41% at four years, with a marked difference according to valve anatomy, the corresponding rates being 72% for patients with a Wilkins score Յ8 and 17% for a score Ͼ8. The comparison with our series must take into account the difference in the patient characteristics: patients were older, had more frequent valve calcification and less good immediate results than in the present series. The quality of the immediate results is an important determinant of late results. The mechanism of poor late results differs according to whether they are related to the continuation of poor immediate results or to a secondary deterioration following an initially successful PMC. After a successful PMC, the major anatomic finding in the patients who had undergone a new intervention on the mitral valve was restenosis, either isolated or, less frequently, associated with mitral regurgitation or with the progression of aortic valve disease. Most patients underwent valve replacement, but the possibility of repeating PMC in selected patients is of interest in further deferring a surgical procedure.
In the present series, we identified three predictors of late deterioration after good immediate results of PMC. Of the two preprocedure related predictors, the most significant was cardiothoracic index. Cardiomegaly is a marker of the advanced stage of heart disease and it was a predictor of late outcome in a large series of CHC (20) .
Another predictor of late deterioration after PMC for restenosis was the type of the initial commissurotomy. The risk of late deterioration was higher after OHC, as compared with CHC. A possible explanation is that the patients in our series who had initially undergone OHC generally had more severe valve disease than in the case of CHC. Other series of PMC for restenosis included only a few patients who had had OHC and did not specifically study those patients (7, 10, 12) .
Mitral valve area after PMC has been shown to be predictive of late results after PMC in series including all procedures, regardless of the immediate results (4, 5) . Even when considering patients who had had good immediate results from PMC, valve area after the procedure remains a predictor of late outcome after PMC for restenosis.
Valve anatomy was not a predictor of late outcome in the present series, whereas it was singled out as the major determinant of late outcome in the only other series reporting midterm follow-up after PMC for recurrent mitral stenosis (11) . In the particular field of recurrent mitral stenosis, we chose to select patients according to the echocardiographic analysis of commissural status in addition to the global evaluation of valve anatomy. Anatomic studies have shown that mitral restenosis after surgical commissurotomy may be associated with recurrent fusion of the commissures, but also to rigidity of the leaflets and/or the subvalvular apparatus, with commissural opening persisting from the first commissurotomy (26, 27) . The latter cases are obviously not suitable for an iterative commissurotomy (27) . Besides the aforementioned differences between the populations involved, the scoring system used to assess valve anatomy differs between different series. Apart from the usual exclusion criteria, the selection of patients who had fusion of both commissures in the present series may have led to the exclusion of the patients with the most severe impairment of valve anatomy. However, it should be noted that no patient had ideal anatomic conditions (anatomic group 1). Therefore, the lack of patients with ideal anatomy, together with the small number of patients with severe valve impairment, probably narrowed the spectrum of anatomic presentations encountered in the present series and therefore limited the importance of valve anatomy in the predictive analysis.
